JPMorgan just pointed investors toward a fast-rising player in AI nuclear energy.
On July 27, 2026, the bank started coverage of BWX Technologies (BWXT) with an overweightrating and a $230 price target.
That target runs through December 2027 and sits about 30% above where the stock traded when the call landed.
BWXT closed at $169.67 on July 28, down 3.89% on the day and down about 10% over the past month, according to Yahoo Finance.
So JPMorgan is making this call while the stock is falling, not climbing. Here is what the bank thinks the market isn’t considering.
What JPMorgan sees in BWX Technologies that the market is missing
The analyst behind the call is Tomohiko Sano, and his argument rests on a simple idea: BWXT makes things almost no one else is allowed to make.
The company holds NRC Category 1 licenses and manufactures heavy nuclear components under deep U.S. government relationships, Investing.com reported.
More AI Power Stocks:
- Morgan Stanley strongly resets GE Vernova stock target
- GE Vernova’s AI power trade has one weak link
- Top energy firm sends key signal on AI’s future after $1.2B deal
Those are not advantages a competitor can copy in a year or two. They take decades and federal clearance to build.
Sano placed BWXT at the intersection of three trends: small modular reactor adoption, commercial nuclear life extensions, and next-generation defense spending.
His view is that demand across all three stays strong for the next decade, not just the next quarter.
Why the Navy contracts anchor the whole thesis
BWXT builds reactor cores and components for the ships that carry the U.S. nuclear fleet.
According to BWXT, the company has delivered more than 420 naval reactor cores to the Naval Nuclear Propulsion Program for more than 70 years.
That track record is why the work keeps coming.
In May, BWXT confirmed more than $1.4 billion in new Navy contracts, according to a press release. The largest piece, worth about $1.285 billion, is the first of five annual awards available in 2030.
For an investor, it means years of booked revenue tied to submarine and carrier programs that Congress funds, regardless of the market cycle.
How SMRs could turn a defense supplier into an energy play
The naval work is the floor. The growth story is nuclear power.
Artificial intelligence data centers need enormous amounts of round-the-clock electricity, and utilities are turning to nuclear power to supply it.
That same demand is lifting power names across the market.
Morgan Stanley recently raised its GE Vernova target to $1,350, arguing the market misread the company’s plan to build more gas turbines for data-center customers.
Related: AI’s energy appetite is reshaping the electric grid
BWXT plays a different role in that build-out. It manufactures the components that reactors are made from.
The company also holds a licensing agreement with Applied Atomics for mPower small modular reactor technology, keeping exclusive manufacturing rights and royalties, Investing.com reported.
A small modular reactor, or SMR, is a compact nuclear plant built in a factory and shipped to a site, rather than constructed piece by piece in the field.
If SMRs scale the way JPMorgan expects, the company that builds their parts stands to benefit, no matter which reactor design wins.
The numbers behind the BWXT bull case
None of this would hold up without the financials to match, and BWXT’s recent quarter gave the bulls something to point to.
First-quarter fiscal 2026 revenue came in at $860.2 million, up about 26% year over year and beating expectations, Investing.com reported.
Adjusted earnings hit $1.12 per share, well above the $0.93 analysts expected.
Q1 fiscal 2026 at a glance:
- Revenue: $860.2 million, up about 26% year over year.
- Adjusted EPS: $1.12, beating the $0.93 estimate.
- Revenue beat expectations by roughly 3%.
The company also raised its 2026 guidance for adjusted EBITDA, earnings, and free cash flow, Investing.com reported.
JPMorgan projects high single-digit to double-digit revenue growth through fiscal 2028, supported by a strong order backlog.
What still has to happen before BWXT reaches $230
A $230 target is a forecast, not a promise, and the path there depends on things that have not happened yet.
The naval revenue is close to being locked. The SMR gain is not.
Small modular reactors remain early. Commercial deployments still depend on licensing timelines, fuel supply, and customer orders that convert from interest into signed contracts.
BWXT also trades at a rich valuation, with a price-to-earnings ratio above 45, according to Stock Analysis. That leaves little room for a stumble.
For readers weighing the stock, a few questions are worth watching:
What to track from here
- Whether new naval task orders arrive on the expected 2030 schedule
- Whether SMR licensing and orders move from announcements to revenue
- Whether margins expand as JPMorgan’s model assumes
Sano is not the only bull. The broader analyst consensus on BWXT carries an average target of$236.71.
The bull case comes down to one bet: that steady defense demand pays investors to wait while the nuclear-power story develops.
If the Navy backlog holds and SMRs scale, BWXT gives investors nuclear exposure without the revenue-free volatility of the startup names.
If SMR adoption stalls, the defense business still anchors the stock, but the 30% gain will likely take longer to arrive.
Related: Leading energy company files for Chapter 11 bankruptcy
